Total Payments
$602.94
2024 Payments
$59.06
Companies
19
Transactions
38
Medicare Patients
3,910
Medicare Billing
$152,793
Payment Breakdown by Category
Food & Beverage$602.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $602.94 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $90.29 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $84.49 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $71.01 | 4 | $0 (2024) |
| ABBVIE INC. | $63.06 | 3 | $0 (2023) |
| Novo Nordisk Inc | $43.96 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $34.51 | 3 | $0 (2017) |
| Ultragenyx Pharmaceutical Inc. | $29.63 | 1 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $22.72 | 2 | $0 (2017) |
| Biogen, Inc. | $20.50 | 1 | $0 (2021) |
| Abbott Laboratories | $19.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $59.06 | 3 | Novartis Pharmaceuticals Corporation ($59.06) |
| 2023 | $125.80 | 6 | Amgen Inc. ($37.03) |
| 2022 | $86.54 | 5 | Amgen Inc. ($53.26) |
| 2021 | $149.25 | 10 | Novo Nordisk Inc ($26.83) |
| 2019 | $73.90 | 5 | Janssen Pharmaceuticals, Inc ($59.21) |
| 2018 | $13.75 | 1 | Purdue Pharma L.P. ($13.75) |
| 2017 | $94.64 | 8 | GlaxoSmithKline, LLC. ($34.51) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Inflammation | ||||||
| 09/29/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PAIN | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Diabetes | ||||||
| 08/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiology | ||||||
| 07/18/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $29.63 | General |
| 03/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Inflammation | ||||||
| 09/12/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Inflammation | ||||||
| 05/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Neuroscience | ||||||
| 09/27/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes Care | ||||||
| 09/15/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROLOGY | ||||||
| 08/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Gastroenterology | ||||||
| 07/07/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PRIMARY CARE | ||||||
| 06/22/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Obesity | ||||||
| 06/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Diabetes | ||||||
| 02/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 584 | 699 | $122,712 | $32,633 |
| 2022 | 10 | 486 | 566 | $92,264 | $23,357 |
| 2021 | 17 | 1,436 | 1,833 | $142,125 | $58,635 |
| 2020 | 9 | 1,404 | 1,743 | $106,350 | $38,168 |
Total Patients
3,910
Total Services
4,841
Medicare Billing
$152,793
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 266 | $47,880 | $10,388 | 21.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 77 | 77 | $8,470 | $5,385 | 63.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $33,550 | $4,976 | 14.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,825 | $3,639 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 79 | $3,002 | $2,202 | 73.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $4,046 | $1,799 | 44.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $7,440 | $783.10 | 10.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,295 | $681.66 | 29.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 15 | $1,515 | $586.05 | 38.7% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 16 | 16 | $1,440 | $571.80 | 39.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,795 | $536.85 | 14.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,260 | $533.68 | 42.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $494.00 | $371.80 | 75.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 14 | $252.00 | $104.06 | 41.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 12 | 12 | $448.00 | $76.44 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 211 | $37,168 | $8,663 | 23.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 62 | 64 | $7,040 | $4,377 | 62.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $28,381 | $4,120 | 14.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 65 | $2,470 | $1,753 | 71.0% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 36 | 36 | $3,240 | $1,283 | 39.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 30 | 30 | $2,700 | $1,080 | 40.0% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 19 | 19 | $1,710 | $684.91 | 40.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $3,135 | $542.36 | 17.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $5,430 | $462.21 | 8.5% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 11 | 11 | $990.00 | $392.04 | 39.6% |
About Dr. Mark Meier, MD
Dr. Mark Meier, MD is a Specialist healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982664264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Meier, MD has received a total of $602.94 in payments from pharmaceutical and medical device companies, with $59.06 received in 2024. These payments were reported across 38 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($602.94).
As a Medicare-enrolled provider, Meier has provided services to 3,910 Medicare beneficiaries, totaling 4,841 services with total Medicare billing of $152,793. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Crestview Hills, KY
- Active Since 03/23/2006
- Last Updated 10/05/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1982664264
Products in Payments
- XARELTO (Drug) $84.49
- ENTRESTO (Drug) $71.01
- VRAYLAR (Drug) $63.06
- Otezla (Drug) $59.45
- XIFAXAN (Drug) $34.74
- Ozempic (Drug) $28.76
- NURTEC ODT (Drug) $28.42
- ANORO (Drug) $22.25
- ADUHELM (Biological) $20.50
- FreeStyle Libre 2 (Device) $19.24
- Repatha (Biological) $18.07
- DEXCOM G6 TRANSMITTER (Device) $17.24
- Wegovy (Drug) $15.20
- LINX Reflux Management System (Device) $14.69
- ORENITRAM (Drug) $13.96
- SYMPROIC (Drug) $13.75
- Aimovig (Biological) $12.77
- BREO (Drug) $12.26
- Myrbetriq (Drug) $11.92
- TOUJEO (Drug) $11.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Crestview Hills
Barry Wendt, Md, MD
Specialist — Payments: $4,013
Specialist $4,013
Dr. Kara Shay, Md, MD
Specialist — Payments: $2,418
Specialist $2,418
Dr. Glen Turner, Md, MD
Specialist — Payments: $943.99
Specialist $943.99
Del Burchell, Md, MD
Specialist — Payments: $596.12
Specialist $596.12
Terry Mcdannold, Md, MD
Specialist — Payments: $338.65
Specialist $338.65
Dr. T Sommerkamp, M.d, M.D
Specialist
Specialist